At the centre of this evolution lie two critical pillars: Nutraceuticals and Ac- tive Pharmaceutical Ingredients (APIs). While traditionally viewed as distinct segments – one focused on wellness and the other on therapeu- tic intervention – the lines between them are in- creasingly blurring. Together, they are shaping a more holistic, innovation-driven future for the pharma industry.